Investing Ideas
/
Australian Pharmaceuticals & Biotech Sustainable Track Record

Australian Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

Neuren Pharmaceuticals

Market Cap: AU$2.7b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$21.50

10.9%

53.0%